col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


232 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: npj Vaccines
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―18 Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants Zineb Lakhrif, Agathe Poupée-Beaugé, Fanny Boursin, Céline Ducournau, Louis Lantier, Nathalie Moiré, et al. (+22)
2 [GO] 2025―Apr―18 Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens Mai-Chi Trieu, Arnold Reynaldi, Wen Shi Lee, Hyon-Xhi Tan, Andrew Kelly, Robyn Esterbauer, et al. (+9)
3 [GO] 2025―Apr―14 A systems biology approach to define SARS-CoV-2 correlates of protection Caolann Brady, Tom Tipton, Oliver Carnell, Stephanie Longet, Karen Gooch, Yper Hall, et al. (+3)
4 [GO] 2025―Mrz―30 RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques Hélène Letscher, Delphine Guilligay, Gregory Effantin, Axelle Amen, Guidenn Sulbaran, Judith A. Burger, et al. (+16)
5 [GO] 2025―Mrz―29 Modeling the impact of early vaccination in an influenza pandemic in the United States Van Hung Nguyen, Pascal Crépey, B. Adam Williams, Verna L. Welch, Jean Marie Pivette, Charles H. Jones, Jane M. True
6 [GO] 2025―Mrz―29 Author Correction: Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic Matthew Z. Dudley, Holly B. Schuh, Amanda Forr, Jana Shaw, Daniel A. Salmon
7 [GO] 2025―Mrz―17 A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years Kai Chu, Jiali Quan, Xiaohui Liu, Qi Chen, Xia Zang, Hanmin Jiang, et al. (+10)
8 [GO] 2025―Mrz―17 Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19 Aileen Ebenig, Mona V. Lange, Michelle Gellhorn Serra, Alexandra Kupke, Roland Plesker, Bingqian Qu, et al. (+3)
9 [GO] 2025―Mrz―01 Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19 Durgesh Kumar, Kshitij Gaikwad, Rushank Gunnale, Sandeep Vishwakarma, Shalu Shukla, Shalini Srivastava, et al. (+10)
10 [GO] 2025―Feb―27 SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner Moe Kobayashi, Nene Kobayashi, Kyoka Deguchi, Seira Omori, Takeshi Ichinohe
11 [GO] 2025―Feb―13 Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology Jaekwan Kim, Alla Kachko, Prabhuanand Selvaraj, David Rotstein, Charles Brandon Stauft, Naveen Rajasagi, et al. (+3)
12 [GO] 2025―Jan―30 Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry Benediktus Yohan Arman, Rebecca Clarke, Tehmina Bharucha, Laura Gomez Fernandez, John Walsby-Tickle, Michael Deats, et al. (+19)
13 [GO] 2025―Jan―13 mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice Xiaoming Liang, Yuxia Yuan, Junbin Wang, Cong Tang, Yun Yang, Yanan Zhou, et al. (+12)
14 [GO] 2025―Jan―10 A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection Jun Liu, Li Wang, Alexandra Kurtesi, Patrick Budylowski, Kyle G. Potts, Haritha Menon, et al. (+20)
15 [GO] 2024―Dez―19 Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron Paolla Beatriz Almeida Pinto, Julia Timis, Kantinan Chuensirikulchai, Qin Hui Li, Hsueh Han Lu, Erin Maule, et al. (+12)
16 [GO] 2024―Nov―29 Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly Ratnadeep Mukherjee, Linn Margrethe Eggesbø, Asia-Sophia Wolf, Ingrid Fadum Kjønstad, Guri Solum, Anthony Ravussin, et al. (+7)
17 [GO] 2024―Nov―25 Author Correction: Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin
18 [GO] 2024―Nov―23 A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines Nhan Thi Ho, Steve G. Hughes, Rose Sekulovich, Van Thanh Ta, Thuong Vu Nguyen, Anh Thi Van Pham, et al. (+12)
19 [GO] 2024―Nov―21 Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity Jernej Pušnik, Werner O. Monzon-Posadas, Emmanuil Osypchuk, Aleksandra Elzbieta Dubiel, Maximilian Baum, Paulina Fehring, et al. (+3)
20 [GO] 2024―Nov―20 Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine Kayvon Modjarrad, Ye Che, Wei Chen, Huixian Wu, Carla I. Cadima, Alexander Muik, et al. (+30)
21 [GO] 2024―Nov―18 Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity Mathieu D’Souza, Alexa Keeshan, Christopher A. Gravel, Marc-André Langlois, Curtis L. Cooper
22 [GO] 2024―Nov―11 Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera Kun Xu, Yaling An, Xueyuan Liu, Haitang Xie, Dedong Li, Ting Yang, et al. (+5)
23 [GO] 2024―Okt―31 Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial Chun K. Chew, Ruijie Wang, Sunita Bavanandan, Norliza Zainudin, Xiaoyuan Zhao, Sumeyya Ahmed, et al. (+29)
24 [GO] 2024―Okt―30 High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters Martin Joseph Lett, Fabian Otte, David Hauser, Jacob Schön, Enja Tatjana Kipfer, Donata Hoffmann, et al. (+13)
25 [GO] 2024―Okt―28 Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin
26 [GO] 2024―Okt―28 Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity Alberto Moreno, Kelly Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, et al. (+9)
27 [GO] 2024―Okt―28 mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination Jacqueline K. Shaia, Priya Shukla, Lee Jampol, Rishi P. Singh
28 [GO] 2024―Okt―22 Broad cross neutralizing antibodies against sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans Yabin Hu, Qian Wu, Fangfang Chang, Jing Yang, Xiaoyue Zhang, Qijie Wang, et al. (+18)
29 [GO] 2024―Okt―16 A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2 Alena Reguzova, Melanie Müller, Felix Pagallies, Dominique Burri, Ferdinand Salomon, Hanns-Joachim Rziha, et al. (+13)
30 [GO] 2024―Okt―09 Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections Amin Alirezaylavasani, Linda Gail Skeie, Ingrid Marie Egner, Adity Chopra, Tuva Børresdatter Dahl, Christian Prebensen, et al. (+10)
31 [GO] 2024―Okt―08 Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens Marcos C. Miranda, Elizabeth Kepl, Mary Jane Navarro, Chengbo Chen, Max Johnson, Kaitlin R. Sprouse, et al. (+20)
32 [GO] 2024―Sep―28 Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL Yongli Zhang, Achun Chen, Daiying Li, Quyu Yuan, Airu Zhu, Jieyi Deng, et al. (+13)
33 [GO] 2024―Sep―19 Author Correction: The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities Hadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, Nadav Michaan, Yoel Angel, Esther Saiag, et al. (+4)
34 [GO] 2024―Sep―18 Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice Daisuke Muraoka, Meng Ling Moi, Osamu Muto, Takaaki Nakatsukasa, Situo Deng, Chieko Takashima, et al. (+10)
35 [GO] 2024―Sep―14 Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine Lisa Singh, Le Bao, Leticia Bode, Ceren Budak, Josh Pasek, Trivellore Raghunathan, et al. (+3)
36 [GO] 2024―Sep―13 Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19 Huong N. Q. Tran, Malcolm Risk, Girish B. Nair, Lili Zhao
37 [GO] 2024―Sep―13 COVID-19 vaccine refusal is driven by deliberate ignorance and cognitive distortions Kamil Fuławka, Ralph Hertwig, Thorsten Pachur
38 [GO] 2024―Sep―09 Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants Sneha Vishwanath, George William Carnell, Martina Billmeier, Luis Ohlendorf, Patrick Neckermann, Benedikt Asbach, et al. (+20)
39 [GO] 2024―Sep―04 Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants Renee L. Hajnik, Jessica A. Plante, Srinivasa Reddy Bonam, Grace H. Rafael, Yuejin Liang, Nicholas C. Hazell, et al. (+8)
40 [GO] 2024―Aug―27 Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy Lin Li, Yusuke Matsui, Mary K. Prahl, Arianna G. Cassidy, Yarden Golan, Unurzul Jigmeddagva, et al. (+19)
41 [GO] 2024―Aug―14 COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales Xinchun Gu, Utkarsh Agrawal, William Midgley, Stuart Bedston, Sneha N. Anand, Rosalind Goudie, et al. (+10)
42 [GO] 2024―Aug―10 Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants Cecília Artico Banho, Beatriz de Carvalho Marques, Lívia Sacchetto, Ana Karoline Sepedro Lima, Maisa Carla Pereira Parra, Alex Ranieri Jeronimo Lima, et al. (+30)
43 [GO] 2024―Aug―03 Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany Sebastian Jäckle, James K. Timmis
44 [GO] 2024―Jul―25 Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV Gang Wang, Abhishek K. Verma, Juan Shi, Xiaoqing Guan, David K. Meyerholz, Fan Bu, et al. (+5)
45 [GO] 2024―Jul―22 A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses Syamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R. Redd, Maria Jose Villar, Jungsoon Lee, Zhuyun Liu, et al. (+12)
46 [GO] 2024―Jul―20 A scoping review of global COVID-19 vaccine hesitancy among pregnant persons Imaima Casubhoy, Alyssa Kretz, Heang-Lee Tan, Laura A. St Clair, Maclaine Parish, Hana Golding, et al. (+9)
47 [GO] 2024―Jul―16 Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network Ali Azizi, Deborah Ogbeni, Gathoni Kamuyu, Lauren M. Schwartz, Carolyn Clark, Peter Spencer, Valentina Bernasconi
48 [GO] 2024―Jul―16 Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, P. Mark Hogarth, et al. (+4)
49 [GO] 2024―Jun―28 Myocarditis associated with COVID-19 vaccination Alessandra Buoninfante, Arno Andeweg, Georgy Genov, Marco Cavaleri
50 [GO] 2024―Jun―26 The direct effect of SARS-CoV-2 virus vaccination on human ovarian granulosa cells explains menstrual irregularities Hadas Bar-Joseph, Yael Raz, Anat Eldar-Boock, Nadav Michaan, Yoel Angel, Esther Saiag, et al. (+4)
51 [GO] 2024―Jun―20 Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses Himanshu Singh Saroha, Swati Bhat, Liza Das, Pinaki Dutta, Michael F. Holick, Naresh Sachdeva, Raman Kumar Marwaha
52 [GO] 2024―Jun―18 Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model Ross N. England, Elizabeth M. Drapeau, Mohamad-Gabriel Alameh, Reihaneh Hosseinzadeh, Drew Weissman, Scott E. Hensley
53 [GO] 2024―Jun―14 Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland Calum Macdonald, Norah Palmateer, Andrew McAuley, Laura Lindsay, Taimoor Hasan, Safraj Shahul Hameed, et al. (+20)
54 [GO] 2024―Mai―28 SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity Muriel Aguilar-Bretones, Yvette den Hartog, Laura L. A. van Dijk, S. Reshwan K. Malahe, Marjolein Dieterich, Héctor Tejeda Mora, et al. (+13)
55 [GO] 2024―Mai―23 Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, Thang Truong, Courtney Meilleur, Lily Chan, et al. (+6)
56 [GO] 2024―Mai―22 Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination Emma S. Chambers, Weigang Cai, Giulia Vivaldi, David A. Jolliffe, Natalia Perdek, Wenhao Li, et al. (+6)
57 [GO] 2024―Mai―18 Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, et al. (+17)
58 [GO] 2024―Mai―18 Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera Annika Rössler, Antonia Netzl, Ludwig Knabl, Samuel H. Wilks, Barbara Mühlemann, Sina Türeli, et al. (+5)
59 [GO] 2024―Apr―08 Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination Alan Chang, Yung-Ming Jeng, Cheng-Maw Ho, Po-Huang Lee
60 [GO] 2024―Apr―05 COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children Katerina Roznik, Jiashu Xue, Georgia Stavrakis, T. Scott Johnston, Divya Kalluri, Rivka Ohsie, et al. (+8)
61 [GO] 2024―Mrz―21 An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza Man Xing, Gaowei Hu, Xiang Wang, Yihan Wang, Furong He, Weiqian Dai, et al. (+8)
62 [GO] 2024―Mrz―20 Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics Sara Terzoli, Paolo Marzano, Valentina Cazzetta, Rocco Piazza, Inga Sandrock, Sarina Ravens, et al. (+15)
63 [GO] 2024―Mrz―06 Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, et al. (+17)
64 [GO] 2024―Mrz―04 A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark Elisabeth O’Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, et al. (+6)
65 [GO] 2024―Feb―28 Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic Matthew Z. Dudley, Holly B. Schuh, Amanda Forr, Jana Shaw, Daniel A. Salmon
66 [GO] 2024―Feb―27 Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models Carla Usai, Erola Ainsua-Enrich, Victor Urrea Gales, Edwards Pradenas, Cristina Lorca-Oró, Ferran Tarrés-Freixas, et al. (+17)
67 [GO] 2024―Feb―23 Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines Ki Hyun Bae, Bhuvaneshwari Shunmuganathan, Li Zhang, Andrew Lim, Rashi Gupta, Yanming Wang, et al. (+9)
68 [GO] 2024―Feb―22 No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines Ahmet Yalcinkaya, Marco Cavalli, Axel Cederholm, Maribel Aranda-Guillén, Anish Behere, Hedvig Mildner, et al. (+11)
69 [GO] 2024―Feb―21 Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, et al. (+17)
70 [GO] 2024―Feb―20 Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection Fan Zhou, Juha Vahokoski, Siri Øyen, Marianne Sævik, Hanne Høyland, Helene H. Sandnes, et al. (+6)
71 [GO] 2024―Feb―05 SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition Claudia Fischer, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Sophie Diexer, et al. (+12)
72 [GO] 2024―Jan―30 Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis Pedro Martínez-Fleta, Esther F. Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, et al. (+18)
73 [GO] 2024―Jan―26 MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans Leonie Mayer, Leonie M. Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Verena Krähling, et al. (+12)
74 [GO] 2024―Jan―20 Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J. Sheward, Changil Kim, et al. (+18)
75 [GO] 2024―Jan―05 Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike Wonyeong Jung, Dansu Yuan, Benjamin Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, et al. (+6)
76 [GO] 2024―Jan―02 An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, et al. (+4)
77 [GO] 2024―Jan―02 Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial Manon L. M. Prins, Geert V. T. Roozen, Cilia. R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, et al. (+18)
78 [GO] 2023―Nov―23 Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States Maria P. Gorenflo, Pamela B. Davis, David C. Kaelber, Rong Xu
79 [GO] 2023―Nov―20 Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants Chon Phin Ong, Kaiming Tang, Pak-Hin Hinson Cheung, Hongzhuo Zhang, Tze-Tung Tang, Yaqian Xue, et al. (+5)
80 [GO] 2023―Nov―20 Outlook of pandemic preparedness in a post-COVID-19 world B. Adam Williams, Charles H. Jones, Verna Welch, Jane M. True
81 [GO] 2023―Okt―26 Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen Simon Doss-Gollin, Sanya Thomas, Byron Brook, Kimia Abedi, Célia Lebas, Floriane Auderset, et al. (+5)
82 [GO] 2023―Okt―25 Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants Nidhi Mittal, Sahil Kumar, Raju S. Rajmani, Randhir Singh, Céline Lemoine, Virginie Jakob, et al. (+11)
83 [GO] 2023―Okt―20 Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2 Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, Viviana Cobos Jiménez, Robert Naughton, Melissa M. Higdon, Maria Deloria Knoll
84 [GO] 2023―Okt―20 A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity Awadalkareem Adam, Birte Kalveram, John Yun-Chung Chen, Jason Yeung, Leslie Rodriguez, Ankita Singh, et al. (+3)
85 [GO] 2023―Okt―11 Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability Lizhou Zhang, Kunal R. More, Amrita Ojha, Cody B. Jackson, Brian D. Quinlan, Hao Li, et al. (+4)
86 [GO] 2023―Okt―09 Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine Mingyuan Li, Lin Jia, Yanbo Xie, Wenlin Ma, Zhihong Yan, Fufeng Liu, et al. (+9)
87 [GO] 2023―Okt―05 COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition Shilin Zhao, Kris Y. W. Lok, Zhen Y. Sin, Ye Peng, Heidi S. L. Fan, Nitya Nagesh, et al. (+15)
88 [GO] 2023―Okt―04 Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines Sabrina E. Vinzón, María V. Lopez, Eduardo G. A. Cafferata, Ariadna S. Soto, Paula M. Berguer, Luciana Vazquez, et al. (+20)
89 [GO] 2023―Sep―29 Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome Mariann Gyöngyösi, Dominika Lukovic, Julia Mester-Tonczar, Katrin Zlabinger, Patrick Einzinger, Andreas Spannbauer, et al. (+16)
90 [GO] 2023―Sep―29 Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Lorna Leal, Judit Pich, Laura Ferrer, Jocelyn Nava, Ruth Martí-Lluch, Ignasi Esteban, et al. (+75)
91 [GO] 2023―Sep―27 Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, James R. Stone
92 [GO] 2023―Sep―14 Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians Srabanti Rakshit, Sudhir Babji, Chaitra Parthiban, Ramya Madhavan, Vasista Adiga, Sharon Eveline J, et al. (+14)
93 [GO] 2023―Sep―01 Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes Rima Hajjo, Ensaf Momani, Dima A. Sabbah, Nancy Baker, Alexander Tropsha
94 [GO] 2023―Aug―12 Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells Robert G. E. Krause, Thandeka Moyo-Gwete, Simone I. Richardson, Zanele Makhado, Nelia P. Manamela, Tandile Hermanus, et al. (+19)
95 [GO] 2023―Aug―08 Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery Cuiping Liu, Lingshu Wang, Jonah S. Merriam, Wei Shi, Eun Sung Yang, Yi Zhang, et al. (+17)
96 [GO] 2023―Aug―04 Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants David N. Springer, Michael Bauer, Iris Medits, Jeremy V. Camp, Stephan W. Aberle, Clemens Burtscher, et al. (+4)
97 [GO] 2023―Jul―15 Maternal and neonatal outcomes of COVID-19 vaccination during pregnancy, a systematic review and meta-analysis Greg Marchand, Ahmed Taher Masoud, Sandeep Grover, Alexa King, Giovanna Brazil, Hollie Ulibarri, et al. (+10)
98 [GO] 2023―Jun―29 Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice Sonia Jangra, Jeffrey J. Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, et al. (+9)
99 [GO] 2023―Jun―09 Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination Patrick D. M. C. Katoto, Liliane N. Byamungu, Amanda S. Brand, Jacques L. Tamuzi, Mireille A. M. Kakubu, Charles S. Wiysonge, Glenda Gray
100 [GO] 2023―Jun―02 Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, Patrizia Leone, Katherina Pugliese, Massimo Spada, et al. (+7)
101 [GO] 2023―Mai―24 Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats Yisheng Song, Jinjin Shao, Guangbiao She, Wanqiang Lv, Guoyu Chen, Jing Liu, et al. (+8)
102 [GO] 2023―Mai―17 Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, Marjolein Dieterich, Lennert Gommers, Daryl Geers, et al. (+15)
103 [GO] 2023―Mai―13 Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection Béré K. Diallo, Caitlín Ní Chasaide, Ting Y. Wong, Pauline Schmitt, Katherine S. Lee, Kelly Weaver, et al. (+5)
104 [GO] 2023―Mai―10 Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, et al. (+27)
105 [GO] 2023―Mai―02 Risk assessment of retinal vascular occlusion after COVID-19 vaccination Jing-Xing Li, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Connie Chen, James Cheng-Chung Wei, Chun-Ju Lin
106 [GO] 2023―Apr―24 Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort Oliver Bürzle, Dominik Menges, Julian D. Maier, Daniel Schams, Milo A. Puhan, Jan Fehr, et al. (+2)
107 [GO] 2023―Apr―22 Resistance to COVID-19 vaccination and the social contract: evidence from Italy Sarah E. Kreps, Douglas L. Kriner
108 [GO] 2023―Apr―12 Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, Rebecca Farkas, Shobana Balasingam, Karin Bok, et al. (+13)
109 [GO] 2023―Mrz―27 Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice Catherine A. Cotter, Jeffrey L. Americo, Patricia L. Earl, Bernard Moss
110 [GO] 2023―Mrz―26 SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies Shikha Shrivastava, Joshua M. Carmen, Zhongyan Lu, Shraddha Basu, Rajeshwer S. Sankhala, Wei-Hung Chen, et al. (+23)
111 [GO] 2023―Mrz―26 PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application Zhihao Zhang, Jinhu Zhou, Peng Ni, Bing Hu, Normand Jolicoeur, Shuang Deng, et al. (+13)
112 [GO] 2023―Mrz―16 Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants Felix Wussow, Mindy Kha, Taehyun Kim, Minh Ly, Marcal Yll-Pico, Swagata Kar, et al. (+3)
113 [GO] 2023―Mrz―11 Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine David Benkeser, Youyi Fong, Holly E. Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, et al. (+34)
114 [GO] 2023―Mrz―06 Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination Yoshifumi Uwamino, Kengo Nagashima, Ayumi Yoshifuji, Shigeru Suga, Mizuho Nagao, Takao Fujisawa, et al. (+8)
115 [GO] 2023―Mrz―03 Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, et al. (+25)
116 [GO] 2023―Feb―25 Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination Hayley Holt, David A. Jolliffe, Mohammad Talaei, Sian Faustini, Giulia Vivaldi, Matthew Greenig, et al. (+8)
117 [GO] 2023―Feb―23 Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes Catherine Milne, Ralf Wagner, François Cano, Martijn Bruysters, Geneviève Waeterloos, Dieter Pullirsch, et al. (+2)
118 [GO] 2023―Feb―23 Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques Catherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, Victoria Giffin, Abishek Chandrashekar, Amanda J. Martinot, et al. (+18)
119 [GO] 2023―Feb―14 Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, et al. (+25)
120 [GO] 2023―Feb―13 Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19 Paulina Kaplonek, Deniz Cizmeci, Jessica Shih-Lu Lee, Sally A. Shin, Stephanie Fischinger, Philipe Gobeil, et al. (+4)
121 [GO] 2023―Feb―13 Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern Patrick O. Azevedo, Natália S. Hojo-Souza, Lídia P. Faustino, Marcílio J. Fumagalli, Isabella C. Hirako, Emiliano R. Oliveira, et al. (+11)
122 [GO] 2023―Feb―02 Is partisan conflict over COVID-19 vaccination eroding support for childhood vaccine mandates? Matt Motta
123 [GO] 2023―Feb―02 Author Correction: “World in motion” - emulsion adjuvants rising to meet the pandemic challenges Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano
124 [GO] 2023―Jan―25 Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants Trung The Tran, Eline Benno Vaage, Adi Mehta, Adity Chopra, Lisa Tietze, Anette Kolderup, et al. (+34)
125 [GO] 2022―Dez―30 Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants Trung The Tran, Eline Benno Vaage, Adi Mehta, Adity Chopra, Lisa Tietze, Anette Kolderup, et al. (+34)
126 [GO] 2022―Dez―19 Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern Juan Shi, Gang Wang, Jian Zheng, Abhishek K. Verma, Xiaoqing Guan, Moffat M. Malisheni, et al. (+4)
127 [GO] 2022―Dez―19 Challenges and developments in universal vaccine design against SARS-CoV-2 variants Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen
128 [GO] 2022―Dez―16 Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial Luke Tzu-Chi Liu, Cheng-Hsun Chiu, Nan-Chang Chiu, Boon-Fatt Tan, Chien-Yu Lin, Hao-Yuan Cheng, et al. (+4)
129 [GO] 2022―Dez―15 Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Franco Wing Tak Cheng, Ching Lung Cheung, Celine Sze Ling Chui, et al. (+7)
130 [GO] 2022―Dez―13 A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine Jenny G. Low, Ruklanthi de Alwis, Shiwei Chen, Shirin Kalimuddin, Yan Shan Leong, Tania Ken Lin Mah, et al. (+15)
131 [GO] 2022―Dez―03 BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children Yannic C. Bartsch, Jessica W. Chen, Jaewon Kang, Madeleine D. Burns, Kerri J. St Denis, Maegan L. Sheehan, et al. (+5)
132 [GO] 2022―Nov―28 Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine Eugenia Z. Ong, Jia Xin Yee, Justin S. G. Ooi, Ayesa Syenina, Ruklanthi de Alwis, Shiwei Chen, et al. (+13)
133 [GO] 2022―Nov―24 Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, et al. (+9)
134 [GO] 2022―Nov―15 Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant Ioannis Sitaras, Henning Jacobsen, Melissa M. Higdon, William E. Dowling, Naor Bar-Zeev, Maria Deloria Knoll
135 [GO] 2022―Nov―15 Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases Porntip Intapiboon, Parichat Uae-areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, et al. (+2)
136 [GO] 2022―Nov―15 Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination Maria G. Byazrova, Ekaterina A. Astakhova, Aygul R. Minnegalieva, Maria M. Sukhova, Artem A. Mikhailov, Alexey G. Prilipov, et al. (+2)
137 [GO] 2022―Nov―12 A potent, broadly protective vaccine against SARS-CoV-2 variants of concern Ziyan Wang, Jiao An, Kunpeng Liu, Pin Yu, Xin Fang, Jiadai Li, et al. (+20)
138 [GO] 2022―Nov―09 Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination Alessandra Buoninfante, Arno Andeweg, Alexander T. Baker, Mitesh Borad, Nigel Crawford, Jean-Michel Dogné, et al. (+13)
139 [GO] 2022―Nov―09 Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, et al. (+24)
140 [GO] 2022―Nov―02 A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, et al. (+9)
141 [GO] 2022―Okt―28 Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates Lochana M. Seenappa, Aniela Jakubowski, Martin P. Steinbuck, Erica Palmer, Christopher M. Haqq, Crystal Carter, et al. (+4)
142 [GO] 2022―Okt―27 Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex Gabriel Dagotto, John D. Ventura, David R. Martinez, Tochi Anioke, Benjamin S. Chung, Mazuba Siamatu, et al. (+9)
143 [GO] 2022―Okt―21 Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harnum, Rodney S. Russell, Michael D. Grant
144 [GO] 2022―Okt―12 Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern Bassel Akache, Tyler M. Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, et al. (+10)
145 [GO] 2022―Okt―01 Understanding change in COVID-19 vaccination intention with network analysis of longitudinal data from Dutch adults Monique Chambon, Wesley G. Kammeraad, Frenk van Harreveld, Jonas Dalege, Janneke E. Elberse, Han L. J. van der Maas
146 [GO] 2022―Sep―23 Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell
147 [GO] 2022―Sep―06 Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, et al. (+10)
148 [GO] 2022―Sep―02 SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates Reza Alimohammadi, Meysam Porgoo, Mohamad Eftekhary, Seyed Hossein Kiaie, Ehsan Ansari Dezfouli, Maryam Dehghani, et al. (+44)
149 [GO] 2022―Aug―19 Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant Ross M. Kedl
150 [GO] 2022―Aug―11 A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia Jane E. Sinclair, Helen J. Mayfield, Kirsty R. Short, Samuel J. Brown, Rajesh Puranik, Kerrie Mengersen, et al. (+2)
151 [GO] 2022―Aug―02 Affordable SARS-CoV-2 protein vaccines for the pandemic endgame James A. Triccas, Joeri Kint, Florian M. Wurm
152 [GO] 2022―Jul―29 Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2 Mariana F. Tioni, Robert Jordan, Angie Silva Pena, Aditya Garg, Danlu Wu, Shannon I. Phan, et al. (+16)
153 [GO] 2022―Jul―26 Rational development of a combined mRNA vaccine against COVID-19 and influenza Qing Ye, Mei Wu, Chao Zhou, Xishan Lu, Baoying Huang, Ning Zhang, et al. (+14)
154 [GO] 2022―Jul―25 Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2 Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, Renate Boss, Philippe Plattet, Sebastian Weigang, et al. (+4)
155 [GO] 2022―Jul―18 An immunological autobiography: my year as a COVID-19 vaccine trial participant Ross M. Kedl
156 [GO] 2022―Jul―06 Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S Dominique J. Barbeau, Judith M. Martin, Emily Carney, Emily Dougherty, Joshua D. Doyle, Terence S. Dermody, et al. (+6)
157 [GO] 2022―Jun―28 Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2 Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Lijuan Yang, Celia Santos, Xueqiao Liu, et al. (+12)
158 [GO] 2022―Jun―03 A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, et al. (+6)
159 [GO] 2022―Mai―26 Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease Bennett J. Davenport, Alexis Catala, Stuart M. Weston, Robert M. Johnson, Jeremy Ardanuy, Holly L. Hammond, et al. (+4)
160 [GO] 2022―Mai―25 Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism Martin F. Bachmann, Mona O. Mohsen, Daniel E. Speiser
161 [GO] 2022―Mai―23 Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice Lilit Grigoryan, Audrey Lee, Alexandra C. Walls, Lilin Lai, Benjamin Franco, Prabhu S. Arunachalam, et al. (+24)
162 [GO] 2022―Mai―13 Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, et al. (+10)
163 [GO] 2022―Apr―26 Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters George Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, Brandon Lillie, Maedeh Naghibosadat, Nariman Shahhosseini, et al. (+16)
164 [GO] 2022―Apr―25 A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2 Philipp A. Ilinykh, Sivakumar Periasamy, Kai Huang, Natalia A. Kuzmina, Palaniappan Ramanathan, Michelle N. Meyer, et al. (+9)
165 [GO] 2022―Apr―08 BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, et al. (+9)
166 [GO] 2022―Mrz―14 Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, Alexander M. Horspool, Jason Kang, Michael T. Winters, et al. (+15)
167 [GO] 2022―Mrz―08 Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Sandra Coppens, et al. (+8)
168 [GO] 2022―Mrz―02 Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination Eng Eong Ooi, Arti Dhar, Richard Petruschke, Camille Locht, Philippe Buchy, Jenny Guek Hong Low
169 [GO] 2022―Mrz―02 Pandemic-response adenoviral vector and RNA vaccine manufacturing Zoltán Kis, Kyungjae Tak, Dauda Ibrahim, Maria M. Papathanasiou, Benoît Chachuat, Nilay Shah, Cleo Kontoravdi
170 [GO] 2022―Feb―28 Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Maggie C. Duncan, et al. (+37)
171 [GO] 2022―Feb―23 An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes Yespolov, et al. (+4)
172 [GO] 2022―Feb―18 Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines Michael Karbiener, Maria R. Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil
173 [GO] 2022―Feb―09 Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice Adrián Lázaro-Frías, Patricia Pérez, Carmen Zamora, Pedro J. Sánchez-Cordón, María Guzmán, Joanna Luczkowiak, et al. (+4)
174 [GO] 2022―Feb―08 Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination Yusuke Miyashita, Takanobu Yoshida, Yuriko Takagi, Hirotake Tsukamoto, Ken Takashima, Takahisa Kouwaki, et al. (+4)
175 [GO] 2022―Jan―21 Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth, et al. (+15)
176 [GO] 2022―Jan―10 Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters Lisa H. Tostanoski, Abishek Chandrashekar, Shivani Patel, Jingyou Yu, Catherine Jacob-Dolan, Aiquan Chang, et al. (+29)
177 [GO] 2021―Dez―21 “World in motion” - emulsion adjuvants rising to meet the pandemic challenges Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano
178 [GO] 2021―Dez―20 Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2 Ria Lassaunière, Charlotta Polacek, Gregers J. Gram, Anders Frische, Jeanette Linnea Tingstedt, Maren Krüger, et al. (+11)
179 [GO] 2021―Dez―16 Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, Shrirang Karve, Anusha Dias, Donghui Zhang, et al. (+24)
180 [GO] 2021―Dez―13 SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B. Morrison, Rajeshwer S. Sankhala, et al. (+11)
181 [GO] 2021―Dez―03 MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge Clement A. Meseda, Charles B. Stauft, Prabhuanand Selvaraj, Christopher Z. Lien, Cyntia Pedro, Ivette A. Nuñez, et al. (+3)
182 [GO] 2021―Dez―03 A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern Mitch Brinkkemper, Philip J. M. Brouwer, Pauline Maisonnasse, Marloes Grobben, Tom G. Caniels, Meliawati Poniman, et al. (+11)
183 [GO] 2021―Nov―30 A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection Claudio Counoupas, Matt D. Johansen, Alberto O. Stella, Duc H. Nguyen, Angela L. Ferguson, Anupriya Aggarwal, et al. (+18)
184 [GO] 2021―Nov―29 Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies Chaojie Zhong, Hongjie Xia, Awadalkareem Adam, Binbin Wang, Renee L. Hajnik, Yuejin Liang, et al. (+10)
185 [GO] 2021―Nov―29 Immune response against SARS-CoV-2 variants: the role of neutralization assays Alicja Maria Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb
186 [GO] 2021―Nov―18 Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant Mayuresh M. Abhyankar, Barbara J. Mann, Jeffrey M. Sturek, Savannah Brovero, G. Brett Moreau, Anjali Sengar, et al. (+7)
187 [GO] 2021―Nov―04 Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination Rafael Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Saahir Khan, Anton Palma, et al. (+22)
188 [GO] 2021―Okt―28 Scientific rationale for developing potent RBD-based vaccines targeting COVID-19 Harry Kleanthous, Judith Maxwell Silverman, Karen W. Makar, In-Kyu Yoon, Nicholas Jackson, David W. Vaughn
189 [GO] 2021―Okt―28 A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge Kathryn McGuckin Wuertz, Erica K. Barkei, Wei-Hung Chen, Elizabeth J. Martinez, Ines Lakhal-Naouar, Linda L. Jagodzinski, et al. (+50)
190 [GO] 2021―Okt―25 Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore Bei Wang, Yun Shan Goh, Tessa Prince, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Pei Xiang Hor, et al. (+12)
191 [GO] 2021―Okt―20 An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats Martijn A. Langereis, Irina C. Albulescu, Judith Stammen-Vogelzangs, Morindy Lambregts, Ken Stachura, Suzan Miller, et al. (+13)
192 [GO] 2021―Okt―14 INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes, Jared Tur, Charles Reed, Richa Kalia, et al. (+18)
193 [GO] 2021―Sep―30 The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America Pablo Argote, Elena Barham, Sarah Zukerman Daly, Julian E. Gerez, John Marshall, Oscar Pocasangre
194 [GO] 2021―Aug―24 Neutralization of MERS coronavirus through a scalable nanoparticle vaccine Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, et al. (+7)
195 [GO] 2021―Aug―16 Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action Franz X. Heinz, Karin Stiasny
196 [GO] 2021―Aug―12 National control laboratory independent lot testing of COVID-19 vaccines: the UK experience Nicola J. Rose, Paul Stickings, Silke Schepelmann, Marc J. A. Bailey, Chris Burns
197 [GO] 2021―Aug―11 Benefit of COVID-19 vaccination accounting for potential risk compensation John P. A. Ioannidis
198 [GO] 2021―Aug―05 Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic Samir Andrade Mendonça, Reka Lorincz, Paul Boucher, David T. Curiel
199 [GO] 2021―Jul―22 A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk, Chad Mire, Natalia Kuzmina, et al. (+7)
200 [GO] 2021―Jun―17 A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells Simon G. P. Funnell, Babak Afrough, John James Baczenas, Neil Berry, Kevin R. Bewley, Rebecca Bradford, et al. (+11)
201 [GO] 2021―Mai―14 Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation Sarah Kreps, Nabarun Dasgupta, John S. Brownstein, Yulin Hswen, Douglas L. Kriner
202 [GO] 2021―Mai―13 Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation Lauren M. Meyers, Andres H. Gutiérrez, Christine M. Boyle, Frances Terry, Bethany G. McGonnigal, Andres Salazar, et al. (+4)
203 [GO] 2021―Mai―13 Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann, Rosemary J. Boyton
204 [GO] 2021―Mai―10 ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets Glenn A. Marsh, Alexander J. McAuley, Gough G. Au, Sarah Riddell, Daniel Layton, Nagendrakumar B. Singanallur, et al. (+38)
205 [GO] 2021―Apr―22 Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine Natalie Thiel, Casey Selwyn, Georgina Murphy, Shmona Simpson, Ajoy C. Chakrabarti
206 [GO] 2021―Apr―21 Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases Velayudhan Mohan Kumar, Seithikurippu R. Pandi-Perumal, Ilya Trakht, Sadras Panchatcharam Thyagarajan
207 [GO] 2021―Apr―19 Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, Jinrong Zhang, Donghui Zhang, Adrien Beauvais, et al. (+32)
208 [GO] 2021―Apr―16 mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents Susanne Rauch, Nicole Roth, Kim Schwendt, Mariola Fotin-Mleczek, Stefan O. Mueller, Benjamin Petsch
209 [GO] 2021―Apr―14 Access to and equitable distribution of COVID-19 vaccine in low-income countries Krishna Prasad Acharya, Tirth Raj Ghimire, Supram Hosuru Subramanya
210 [GO] 2021―Apr―13 Considerations for bioanalytical characterization and batch release of COVID-19 vaccines Gautam Sanyal, Anna Särnefält, Arun Kumar
211 [GO] 2021―Mrz―30 Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
212 [GO] 2021―Mrz―25 The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization Jing Zou, Xuping Xie, Camila R. Fontes-Garfias, Kena A. Swanson, Isis Kanevsky, Kristin Tompkins, et al. (+4)
213 [GO] 2021―Mrz―19 Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan, Liesbeth Dekking, Ella van Huizen, Jessica Vreugdenhil, et al. (+21)
214 [GO] 2021―Mrz―19 Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2 Hansam Cho, Yuyeon Jang, Ki-Hoon Park, Hanul Choi, Aleksandra Nowakowska, Hee-Jung Lee, et al. (+6)
215 [GO] 2021―Feb―22 SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates Nikolaos C. Kyriakidis, Andrés López-Cortés, Eduardo Vásconez González, Alejandra Barreto Grimaldos, Esteban Ortiz Prado
216 [GO] 2021―Feb―11 Promoting versatile vaccine development for emerging pandemics Joshua T. Monrad, Jonas B. Sandbrink, Neil G. Cherian
217 [GO] 2021―Jan―25 Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters Rebecca L. Brocato, Steven A. Kwilas, Robert K. Kim, Xiankun Zeng, Lucia M. Principe, Jeffrey M. Smith, Jay W. Hooper
218 [GO] 2021―Jan―04 SARS-CoV-2 structural features may explain limited neutralizing-antibody responses Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser
219 [GO] 2020―Nov―03 Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections Jay Epstein, W. Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
220 [GO] 2020―Okt―23 Navigating facilitated regulatory pathways during a disease X pandemic Shmona Simpson, Ajoy Chakrabarti, David Robinson, Keith Chirgwin, Murray Lumpkin
221 [GO] 2020―Okt―16 Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2 Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell
222 [GO] 2020―Okt―08 Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Matthew P. Bruce, Jennifer Barr, Shawn Todd, et al. (+14)
223 [GO] 2020―Sep―28 Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, Mark J. G. Bakkers, Gijs Hardenberg, Frank Wegmann, et al. (+18)
224 [GO] 2020―Sep―04 Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein René Wintjens, Amanda Makha Bifani, Pablo Bifani
225 [GO] 2020―Jul―27 Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 Simon P. Graham, Rebecca K. McLean, Alexandra J. Spencer, Sandra Belij-Rammerstorfer, Daniel Wright, Marta Ulaszewska, et al. (+36)
226 [GO] 2020―Jul―06 Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic Leonardo M. R. Ferreira, Mohammed A. Mostajo-Radji
227 [GO] 2020―Jun―15 Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens Jayanthi Wolf, Samantha Bruno, Michael Eichberg, Risat Jannat, Sharon Rudo, Susan VanRheenen, Beth-Ann Coller
228 [GO] 2020―Mai―28 Universal coronavirus vaccines: the time to start is now Luca T. Giurgea, Alison Han, Matthew J. Memoli
229 [GO] 2020―Mai―25 Certainty of success: three critical parameters in coronavirus vaccine development David C. Kaslow
230 [GO] 2020―Apr―30 COVID-19 vaccines: breaking record times to first-in-human trials Young Chan Kim, Barbara Dema, Arturo Reyes-Sandoval
231 [GO] 2020―Mrz―06 The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines Weilong Shang, Yi Yang, Yifan Rao, Xiancai Rao
232 [GO] 2019―Dez―06 Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad A. Behzadi, Damien Friel, Arvind Rajabhathor, et al. (+11)
 [1] 

232 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec